Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) FCF Margin (2021 - 2025)

HeartSciences' FCF Margin history spans 5 years, with the latest figure at 96497.15% for Q4 2025.

  • For Q4 2025, FCF Margin fell 9835394.0% year-over-year to 96497.15%; the TTM value through Jan 2026 reached 84569.42%, down 8988465.0%, while the annual FY2025 figure was 170486.23%, 13750429.0% down from the prior year.
  • FCF Margin reached 96497.15% in Q4 2025 per HSCS's latest filing, up from 102808.79% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 8961.73% in Q3 2024 to a low of 102808.79% in Q3 2025.
  • Average FCF Margin over 5 years is 34140.55%, with a median of 28737.58% recorded in 2022.
  • Peak YoY movement for FCF Margin: soared 6072865bps in 2023, then crashed -11177052bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 9587.0% in 2021, then plummeted by -493bps to 56842.34% in 2022, then skyrocketed by 55bps to 25388.18% in 2023, then soared by 107bps to 1856.79% in 2024, then plummeted by -5297bps to 96497.15% in 2025.
  • Per Business Quant, the three most recent readings for HSCS's FCF Margin are 96497.15% (Q4 2025), 102808.79% (Q3 2025), and 36566.44% (Q2 2025).